Topical Pain Relief companies

  • Report ID: 2473
  • Published Date: May 21, 2025
  • Report Format: PDF, PPT

Companies Dominating the Topical Pain Relief Landscape

    The global players involved in the topical pain relief market are emphasizing the wide range of marketing tactics to enhance their industrial presence across the world. Companies such as Johnson & Johnson, GSK, and Sanofi held a lucrative share of 30.7% in the market. One of the key trends opted by the market players includes product innovation, followed by improved regulatory approvals. Sun Pharma and Cipla are focusing on providing affordable medications in India and Africa, aiming to establish their footprint internationally. Hence, these trends draw the interest of several key players, thereby encouraging a healthy competition in the market.

    Here is a list of key players in the global topical pain relief market:

    • Johnson & Johnson (USA)
      • Company Overview 
      • Business Strategy 
      • Key Product Offerings 
      • Financial Performance 
      • Key Performance Indicators 
      • Risk Analysis 
      • Recent Development 
      • Regional Presence 
      • SWOT Analysis 
    • GlaxoSmithKline (UK)
    • Sanofi (France)
    • Pfizer (USA)
    • Hisamitsu Pharmaceutical (Japan)
    • Bayer (Germany)
    • Perrigo (Ireland)
    • Sun Pharmaceutical (India)
    • Teva Pharmaceutical (Israel)
    • Reckitt Benckiser (UK)
    • Taisho Pharmaceutical (Japan)
    • Cipla (India)
    • Hikma Pharmaceuticals (UK)
    • Mylan (USA)
    • Taro Pharmaceutical (Israel)
    • CSPC Pharmaceutical (China)
    • Dr. Reddy’s Laboratories (India)
    • Endo International (USA)
    • Blackmores (Australia)
    • Kotra Pharma (Malaysia)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of topical pain relief is assessed at USD 13.8 billion.

Topical Pain Relief Market size was valued at USD 12.9 billion in 2024 and is expected to reach USD 25.4 billion by 2037, expanding at around 6.2% CAGR during the forecast period i.e., between 2025-2037.

North America industry is set to account for largest revenue share of 40.8% by 2037.

The major players in the market are Reckitt Benckiser Group plc, Teikoku Pharma USA, Inc., Topical BioMedics, Inc., Sun Pharmaceutical Industries Ltd., AdvaCare Pharma®, Sanofi, Johnson & Johnson Services, Inc., Novartis AG,
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos